NCT00438386View on ClinicalTrials.gov

Aripiprazole for the Treatment of Refractory Anxiety

PHASE4CompletedINTERVENTIONAL

Timeline

Start Date

April 30, 2005

Study Completion Date

June 30, 2007

Conditions

Generalized Anxiety DisorderPanic Disorder

Interventions

DRUG

Aripiprazole

Trial Locations (1)

02114

Center for Anxiety and Traumatic Stress Disorders at Massachusetts General Hospital, Boston

Sponsors

Collaborators (1)

Bristol-Myers Squibb

All Listed Sponsors

collaborator

Bristol-Myers Squibb

INDUSTRY

lead

Massachusetts General Hospital

OTHER

NCT00438386 - Aripiprazole for the Treatment of Refractory Anxiety | Biotech Hunter | Biotech Hunter